Shalby Ltd

Shalby Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window will be shut from October 01, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter and half-year ended September 30, 2026. All insiders have been advised not to trade in the company's securities during this period. The company's Insider Trading Code is available on its website.

Shalby Ltd has announced its 22nd Annual General Meeting (AGM) scheduled for September 10, 2026, at 4:00 PM IST. The meeting will be conducted via Video Conferencing (VC)/Other Audio-Visual Means (OAVM). The Annual Report for FY 2025-26 and the AGM Notice are being sent electronically to members with registered email addresses. For members without registered emails, a letter containing a weblink to access the complete Annual Report and AGM Notice has been dispatched. The company is also providing remote e-voting facility through NSDL from September 5 to September 9, 2026. Members can register to speak at the AGM by September 3, 2026.

Mr. Deepak Anand has resigned as the Chief Executive Officer of Shalby Medtech Limited, a wholly-owned subsidiary of Shalby Ltd. His resignation is effective from the close of business hours on September 4, 2026. Mr. Anand is relocating abroad for personal reasons, which he states is the sole reason for his departure. He has assured full cooperation during the transition period to ensure a smooth handover of responsibilities. The company has confirmed no other material reasons for his resignation.

Shalby Limited has submitted its Business Responsibility & Sustainability Report (BRSR) for the Financial Year 2025-26, as required by SEBI (LODR) Regulations. The report is an integral part of the company's Annual Report for the same fiscal year. It details the company's corporate identity, operational scope, employee data, and market reach. The BRSR is available on the company's website and has been uploaded to the stock exchange portals. The report covers standalone operations, with 100% turnover from Hospital Activities and Hospital Services.

Shalby Limited has announced its 22nd Annual General Meeting (AGM) scheduled for Thursday, September 10, 2026, at 4:00 PM IST, to be conducted via Video Conferencing (VC) / Other Audio Visual Means (OAVM). The company has also released its Annual Report for the Financial Year 2025-26. The AGM will include the adoption of audited standalone and consolidated financial statements for FY 2025-26 and ratification of remuneration for cost auditors for FY 2026-27. A cut-off date of September 3, 2026, has been set for remote e-voting, which will commence on September 5, 2026, and conclude on September 9, 2026. The notice and annual report are available on the company's website and have been sent to members electronically.

Shalby Limited's Board of Directors convened on August 12, 2026, approving the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The board also approved the Cost Audit Report for FY26 and appointed Mr. Shanay Vikram Shah as Whole-Time Director for five years, effective August 12, 2026, subject to shareholder approval. Additionally, PricewaterhouseCoopers Services LLP was appointed as Internal Auditors for FY27. The board also noted the acquisition of a 0.67% stake in Shalby Global Technologies Pte. Ltd. by Shalby Medtech Limited, making SGTPL a wholly-owned subsidiary.

Shalby Ltd announced the appointment of Mr. Shanay Vikram Shah as an Additional Director, designated as Whole-Time Director, effective August 12, 2026. This appointment is for a term of five consecutive years, subject to shareholder approval at the upcoming Annual General Meeting. Mr. Shah, aged 35, holds degrees from the University of Warwick and Imperial College London, and is a Chartered Financial Analyst (CFA). He is a promoter of the company and has over a decade of experience in the healthcare industry, overseeing various business functions. He will also serve as Key Managerial Personnel.

Shalby Limited's Board of Directors convened on August 12, 2026, to approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The board also approved the appointment of Mr. Shanay Vikram Shah as an Additional Director designated as Whole-Time Director for five years, subject to shareholder approval at the upcoming AGM. Additionally, the company approved the appointment of PricewaterhouseCoopers Services LLP as Internal Auditors for FY27 and noted the acquisition of remaining 0.67% shares in Shalby Global Technologies Pte. Ltd. by Shalby Medtech Limited, making it a wholly-owned subsidiary.

Shalby Ltd's Management Committee has approved availing working capital facilities totaling ₹129.70 crore from Kotak Mahindra Bank Limited. This includes ₹119.70 crore for its overseas step-down subsidiary, Shalby Advanced Technologies, Inc., USA, to meet its working capital requirements. The remaining ₹10 crore will be availed by Shalby Ltd itself, through Working Capital Demand Loan (WCDL) or Cash Credit facilities. The company states that providing the necessary support for the subsidiary's credit facilities is in its overall interest, and no significant financial or operational impact is foreseen from this transaction.

Shalby Ltd has revised the date of its Board Meeting, originally scheduled for August 5, 2026, to August 12, 2026. The meeting is to consider the unaudited financial results for the quarter ended June 30, 2026 (Q1 FY27). Due to unavoidable exigencies, the meeting date has been postponed. Consequently, the trading window, which was closed from July 1, 2026, will remain closed and reopen 48 hours after the conclusion of the rescheduled Board Meeting, in compliance with the company's Code of Conduct for Prohibition of Insider Trading.